Fidelity AdvisorĀ® Biotechnology Fund Class T (FBTTX)

17.43
Net Asset Value
-0.17%
1 Day
-3.97%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
3.5
Sales Expenses
1.46%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Performance

1 month-16.96% 3 years+30.58%
3 months-14.93% 5 years+27.02%
1 year+25.59% Since inception+6.09%
Data through --

Peer Comparisonvs. Health

 FBTTXCategory
Performance 5-yr return+27.02%+23.71%
Expense ratio1.46%1.46%
Risk 5 year sharpe ratio1.301.54
Net assets$1.5B$2.6B
Average market cap$12.0B$31.7B
Average P/E33.426.8
Portfolio turnover22%22%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureRajiv Kaul / 8 Years
Minimal initial investment$2,500.00
Minimum IRA investment$500.00

Holdings

U.S. stock96.63%
International stock1.79%
Cash1.37%
Other0.22%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences Inc13.70%
AMGN Amgen Inc9.87%
BIIB Biogen Idec Inc6.55%
CELG Celgene Corporation5.30%
ALXN Alexion Pharmaceuticals, Inc.4.70%
ICPT Intercept Pharmaceuticals Inc4.09%
REGN Regeneron Pharmaceuticals, Inc.3.65%
VRTX Vertex Pharmaceuticals Inc3.04%
BMRN Biomarin Pharmaceutical, Inc.2.39%
INCY Incyte Corp Ltd1.70%

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.